findmyKOL

Wasiq Rawasia, MD

Basic profile

Cardiovascular Disease

ORCID↗NPI↗
✓ Full record
RegionHouston, TX · South CentralSpecialtyCardiovascular DiseaseFocusCardiology
Active KOLfindmyKOL type: RegionalLatest publication2025Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Wasiq Rawasia is a Cardiology physician. OpenAlex indexes 31 publications with 13,206 citations (h-index 14). By OpenAlex citation count, this profile ranks in the top 10% of Cardiovascular Disease profiles in the findmyKOL directory.

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
31publications

Distinct works indexed by OpenAlex, matched via ORCID.

13,206citations

Total citations across indexed works.

14h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
28companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

13325 Hargrave Rd Ste 150
Houston, TX 770704541

Telephone

281-955-7863

Provider last certified this registry record 24 Apr 2023.

View the NPPES registry record

Industry payments

28 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    72.2%
    Beta blocker19.3%
    Metoprolol Succinate62%Carvedilol39%
    Part D≥27 patients
    Statin15.7%
    Rosuvastatin Calcium55%Atorvastatin Calcium45%
    Part D≥22 patients

    + 7 more classes in this area

  • Blood & clotting

    19.3%
    P2Y12 inhibitor14%
    Clopidogrel82%Brilinta18%
    Part D<11 patients
    Factor Xa inhibitor5.3%
    Eliquis100%
    Part D≥12 patients
  • Anti-infectives

    4.9%
    Tetracycline-class Drug4.9%
    Minocycline Hcl100%
    Part D≥23 patients
Where care is delivered (Part B)76.6% facility · 23.4% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”